Intranasal Pharmacokinetics of Morphine ARER, a Novel Abuse-Deterrent Formulation: Results from a Randomized, Double-Blind, Four-Way Crossover Study in Nondependent, Opioid-Experienced Subjects

OBJECTIVE: To investigate the pharmacokinetics (PK) of Morphine ARER, an extended-release (ER), abuse-deterrent formulation of morphine sulfate after oral and intranasal administration. METHODS: This randomized, double-blind, double-dummy, placebo-controlled, four-way crossover study assessed the PK...

Descripción completa

Detalles Bibliográficos
Autores principales: Webster, Lynn R., Pantaleon, Carmela, Iverson, Matthew, Smith, Michael D., Kinzler, Eric R., Aigner, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937443/
https://www.ncbi.nlm.nih.gov/pubmed/29849845
http://dx.doi.org/10.1155/2018/7276021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937443/
https://www.ncbi.nlm.nih.gov/pubmed/29849845
http://dx.doi.org/10.1155/2018/7276021

Ejemplares similares